FDA NDC Directory · JSON-LD · Markdown

OXYBUTYNIN CHLORIDE

NDC 64980-734 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerRISING PHARMA HOLDINGS, INC.
Marketing categoryAbbreviated NDA (generic) · App ANDA209025
Dosage form / routeTABLET · ORAL
Active ingredientsOXYBUTYNIN CHLORIDE (2.5 mg/1)
Marketing started20260721
Package count1

External sources

Source: openFDA. Public-domain (CC0).